Serious safety events in rituximab‐treated multiple sclerosis and related disorders

INTRODUCTION: Studies investigating rates and risk factors for serious safety events (SSEs) during rituximab treatment of multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), and related disorders are limited. METHODS: Rituximab‐treated patients with MS, NMOSD, or related disord...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Clin Transl Neurol
Main Authors: Vollmer, Brandi L., Wallach, Asya I., Corboy, John R., Dubovskaya, Karolina, Alvarez, Enrique, Kister, Ilya
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7480911/
https://ncbi.nlm.nih.gov/pubmed/32767531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51136
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados